A stability-indicating HPLC method for estimation of doxylamine succinate in tablets and characterization of its major alkaline stress degradation product
Open Access
- 8 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Future Journal of Pharmaceutical Sciences
- Vol. 7 (1), 1-13
- https://doi.org/10.1186/s43094-021-00276-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- ENANTIOSELECTIVE QUANTIFICATION OF DOXYLAMINE IN HUMAN PLASMA BY HPLCJournal of Liquid Chromatography & Related Technologies, 2011
- Histamina, receptores de histamina e anti-histamínicos: novos conceitosAnais Brasileiros de Dermatologia, 2010
- The role of degradant profiling in active pharmaceutical ingredients and drug productsAdvanced Drug Delivery Reviews, 2007
- On-line sample treatment and FT-IR determination of doxylamine succinate in pharmaceuticalsTalanta, 2006
- Development of validated stability-indicating assay methods—critical reviewJournal of Pharmaceutical and Biomedical Analysis, 2002
- Chromatographic analysis of phenethylamine–antihistamine combinations using C8, C18 or cyano columns and micellar sodium dodecyl sulfate–pentanol mixturesThe Analyst, 2001
- Simultaneous Determination of Pyridoxine Hydrochloride and Doxylamine Succinate from Tablets by Ion Pair Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC)Drug Development and Industrial Pharmacy, 1999
- Spectrophotometric Determination of the Antihistamines, Carbinoxamine Maleate and Doxylamine Succinate, in anN-Cetylpyridinium Chloride Micellar MediumAnalytical Letters, 1996
- Characterization of over‐the‐counter cough/cold medications by liquid chromatography/electrospray mass spectrometryRapid Communications in Mass Spectrometry, 1995